Generation of an induced pluripotent stem cell line (SJTUGHi001-A) from a patient with Retinitis Pigmentosa carrying c.77C > T mutation in RAX2 gene

被引:0
|
作者
Bai, Xinyue [1 ,2 ,3 ,4 ,5 ,6 ,7 ]
Chen, Jieqiong [1 ,2 ,3 ,4 ,5 ,6 ,7 ]
Zhao, Xiaohuan [1 ,2 ,3 ,4 ,5 ,6 ,7 ]
Zhu, Xinyue [1 ,2 ,3 ,4 ,5 ,6 ,7 ]
Ding, Xiaoyan [8 ]
Zhang, Ting [1 ,2 ,3 ,4 ,5 ,6 ,7 ]
Jiang, Mei [1 ,2 ,3 ,4 ,5 ,6 ,7 ]
Sun, Xiaodong [1 ,2 ,3 ,4 ,5 ,6 ,7 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Sch Med, Dept Ophthalmol, Shanghai, Peoples R China
[2] Natl Clin Res Ctr Eye Dis, Shanghai, Peoples R China
[3] Shanghai Clin Res Ctr Eye Dis, Shanghai, Peoples R China
[4] Shanghai Key Clin Specialty, Shanghai, Peoples R China
[5] Shanghai Key Lab Ocular Fundus Dis, Shanghai, Peoples R China
[6] Shanghai Engn Ctr Visual Sci & Photomed, Shanghai, Peoples R China
[7] Shanghai Engn Ctr Precise Diag & Treatment Eye Dis, Shanghai, Peoples R China
[8] Chinese Acad Sci, CAS Ctr Excellence Mol Cell Sci, Stem Cell Core Facil, Shanghai, Peoples R China
基金
中国国家自然科学基金;
关键词
D O I
10.1016/j.scr.2024.103390
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Retinitis pigmentosa (RP) is a group of genetically heterogeneous retinopathy resulting in irreversible loss of vision. Mutations in RAX2 gene has been related to RP with mechanisms unclear. Here, we generated a human induced pluripotent stem cell (iPSC) line from peripheral blood mononuclear cells of a RP patient carrying c.77C > T mutation in RAX2 gene. This cell line was induced by integration-free episomal vectors and validated for pluripotency and differentiation capacity, which may serve as a model to study the role of RAX2 in RP pathogenesis.
引用
收藏
页数:4
相关论文
共 50 条
  • [21] Generation of an induced pluripotent stem cell line XJHi001-A from a fibronectin glomerulopathy patient carrying a heterozygous NM_212482.2 (C.5888-1G> C) mutation in the FN1 gene
    She, Lecheng
    Li, Xiayin
    Bai, Ming
    STEM CELL RESEARCH, 2023, 72
  • [22] Generation of an induced pluripotent stem cell line from a patient carrying FBN1/c.6734 G > A mutation
    Pan, Ziwei
    Wang, Hongkun
    Wang, Hao
    Liu, Yong
    Liang, Ping
    STEM CELL RESEARCH, 2021, 55
  • [23] Establishment of human induced pluripotent stem cell line MURAi001-A from skin fibroblasts of a patient carrying a c.4404A > G mutation in the TET1 gene
    Tangprasittipap, Amornrat
    Innachai, Pawarit
    Chumchuen, Sukanya
    Chiangjong, Wararat
    Jinawath, Natini
    Sirachainan, Nongnuch
    Hongeng, Suradej
    STEM CELL RESEARCH, 2024, 79
  • [24] Generation of an induced pluripotent stem cell line (ICNDXHi001-A) from a patient with frontotemporal dementia carrying a heterozygous mutation c.796C > G (p.L266V) in MAPT
    Cai, Huimin
    Pang, Yana
    Jia, Longfei
    STEM CELL RESEARCH, 2022, 59
  • [25] Generation of the induced pluripotent stem cell line IOCVi001-A from a patient with the MFRP-related retinitis pigmentosa-nanophthalmos syndrome
    Mora-Roldan, German A.
    Nava, Jessica
    Gazarian, Karlen
    Zenteno, Juan Carlos
    STEM CELL RESEARCH, 2024, 75
  • [26] Generation of an induced pluripotent stem cell line from a Brugada syndrome patient carrying SCN5A/c.3118G>C mutation
    Fan, Hangping
    Su, Jun
    Wang, Xiaochen
    Wang, Hao
    Chen, Xianzhen
    Sun, Yaxun
    Jiang, Chenyang
    Liang, Ping
    STEM CELL RESEARCH, 2024, 80
  • [27] Generation of a human induced pluripotent stem cell line (SBWCHi001-A) from a patient with NEDSDV carrying a pathogenic mutation in CTNNB1 gene
    Yan, Rui
    Liu, Pengyu
    Li, Fake
    Chu, Meng
    Lei, Jiafan
    Wang, Feng
    Luo, Liangping
    Xu, Xueqing
    STEM CELL RESEARCH, 2020, 49
  • [28] Generation of a human induced pluripotent stem cell line (FSMi001-A) from fibroblasts of a patient carrying heterozygous mutation in the REEP1 gene
    Baggiani, Matteo
    Santorelli, Filippo Maria
    Mero, Serena
    Privitera, Flavia
    Damiani, Devid
    Tessa, Alessandra
    STEM CELL RESEARCH, 2024, 79
  • [29] Generation of a human induced pluripotent stem cell line from a female patient carrying LZTR1 gene mutation
    Ruan, Jinghua
    Wu, Mengqing
    Xiang, Jiakai
    Hui, Xianrui
    Yang, Lijun
    Lin, Ru
    Xu, Weize
    Shu, Qiang
    STEM CELL RESEARCH, 2024, 81
  • [30] Establishment of an induced pluripotent stem cell line from a retinitis pigmentosa patient with compound heterozygous CRB1 mutation
    Zhang, Xiao
    Zhang, Dan
    Chen, Shang-Chih
    Lamey, Tina
    Thompson, Jennifer A.
    McLaren, Terri
    De Roach, John N.
    Chen, Fred K.
    McLenachan, Samuel
    STEM CELL RESEARCH, 2018, 31 : 147 - 151